Suppr超能文献

成熟心脏淋巴管在动脉粥样硬化、心肌梗死和心力衰竭中的功能与再生

Functions and Regeneration of Mature Cardiac Lymphatic Vessels in Atherosclerosis, Myocardial Infarction, and Heart Failure.

作者信息

Zhang Yaqi, Bai Yingnan, Jing Qing, Qian Juying

机构信息

Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao-Tong University School of Medicine, Shanghai, China.

出版信息

Lymphat Res Biol. 2018 Dec;16(6):507-515. doi: 10.1089/lrb.2018.0023. Epub 2018 Oct 19.

Abstract

Cardiac lymphatic vessels play a vital role in maintaining cardiac homeostasis both under physiological and pathological conditions. Clearer illustration of the anatomy of cardiac lymphatics has been achieved by fluorescence exhibition comparing to dye injection. Besides, identification of specific lymphatic markers in recent decades paves the way for researches in development and regeneration of cardiac lymphatics, such as VEGF-C/VEGFR-3, EphB4/ephrin-B2, Prox-1, Podoplanin, and Lyve-1. Knocking out each of these markers in mice model also reveals the signaling pathways instructing the formation of cardiac lymphatics. In the major cardiovascular disease series of atherosclerosis, myocardial infarction (MI), and heart failure, cardiac lymphatics regulate the transportation of extravasated proteins and lipids, inflammatory and immune responses, as well as fluid balance. Elementary intervention methods, such as lymphatic factor protein injection VEGF-C, are applied in murine MI models to restore or enhance functions of lymphatic vessels, achieving improvements in cardiac function. Also, data from our laboratory showed that intramyocardial EphB4 injection also improved lymphatic regeneration in mouse MI model. Therefore, we believe that enhancing functions and regeneration of mature cardiac lymphatic vessels in cardiovascular diseases is of great potential therapeutic meaning in the future.

摘要

心脏淋巴管在生理和病理条件下对维持心脏内环境稳定起着至关重要的作用。与染料注射相比,通过荧光显示已更清晰地阐明了心脏淋巴管的解剖结构。此外,近几十年来特定淋巴管标志物的鉴定为心脏淋巴管发育和再生的研究铺平了道路,如血管内皮生长因子C/血管内皮生长因子受体-3、EphB4/ Ephrin-B2、Prox-1、血小板内皮细胞黏附分子-1和淋巴管内皮透明质酸受体-1。在小鼠模型中敲除这些标志物中的每一种也揭示了指导心脏淋巴管形成的信号通路。在动脉粥样硬化、心肌梗死(MI)和心力衰竭等主要心血管疾病系列中,心脏淋巴管调节外渗蛋白质和脂质的运输、炎症和免疫反应以及液体平衡。在小鼠MI模型中应用了诸如注射淋巴管因子蛋白血管内皮生长因子C等基本干预方法,以恢复或增强淋巴管功能,从而改善心脏功能。此外,我们实验室的数据表明,心肌内注射EphB4也改善了小鼠MI模型中的淋巴管再生。因此,我们认为增强成熟心脏淋巴管在心血管疾病中的功能和再生在未来具有巨大的潜在治疗意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验